WGS Competitors & Alternatives
Compare GeneDx Holdings Corp. with similar stocks in the same industry
Diagnostics & Research
WGS
Main Stock$60.34
Tradestie Score
64
Market Cap
$3.26B
Revenue Growth
0.2%
Analyst Upside
+27.6%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SEZL
Sezzle Inc. Common Stock
|
$148.42
|
$2.68B | 23.5 | 64 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$62.01
|
$2.24B | - | 59 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$17.58
|
$2.22B | - | 55 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$86.05
|
$1.77B | - | 66 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$14.90
|
$1.42B | - | 67 | Compare |
|
NEOG
Neogen Corp
|
$8.82
|
$1.26B | - | 49 | Compare |
|
OPK
Opko Health Inc.
|
$1.46
|
$1.23B | - | 56 | Compare |
|
NEO
NeoGenomics, Inc.
|
$11.42
|
$1.13B | - | 57 | Compare |
|
CDNA
CareDx, Inc.
|
$25.22
|
$798.40M | - | 66 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$18.23
|
$719.31M | - | 48 | Compare |
More WGS Analysis
Data updated: Jun 23, 2026 | Industry: Diagnostics & Research (SIC 8000)
36 stocks in this industry